Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ( Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics”, today announced that the World Intellectual Property Organization (WIPO) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (PCT) patent…


Previous articleFilament Health Announces Pre-ind Meeting With United States Food And Drug Administration
Next articlePsychedelic Bulletin: Numinus to Enter U.S. Clinics Market; Mydecine Announces Reverse Stock-Split; Are Magic Mushrooms Giving Investors a Bad Trip?